Method and system for acquiring spectral data for use in assessing risk of breast cancer

A system for enabling a determination of a risk of developing breast cancer of a subject by in vivo acquisition of spectral data of a breast tissue of the subject, comprising:

• a. a magnetic resonance spectroscopy device to obtain a level of a spectral signal at 3.15 and 3.19 ppm (parts per million), within a breast tissue of the subject, and
• b. a comparator for comparing (i) the level of the spectral signal obtained in step a. with (ii) a reference level of a spectral signal at 3.15 and 3.19 ppm from a breast of a healthy subject, to determine whether (i) the level of the signal obtained in step a. exceeds the reference level of a healthy subject from step b (ii), (ii) is comparable to that of a subject known to be at elevated risk, or (ii) is elevated to the level of persons known to be carrying a gene mutation.

A system for enabling a determination of a risk of developing breast cancer of a subject by in vivo acquisition of spectral data of a breast tissue of a subject, comprising:

• a. a processor for processing spectral data obtained in vivo from the breast tissue of the subject using a magnetic resonance spectroscopy device to obtain a level of a spectral signal at 3.15 and 3.19 ppm (parts per million), and
• b. a comparator for comparing (i) the level of the spectral signal obtained in step a. with (ii) a reference level of a spectral signal at 3.15 and 3.19 ppm from a breast tissue of a healthy subject, to determine whether the level of the signal obtained in step a. (i) exceeds the reference level of a healthy subject from step (b) (ii), (ii) is comparable to that of a subject known to be at elevated risk, or (iii) is elevated to the level of persons known to be carrying a gene mutation.